TrialMedicine2016

A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma: The TCOG 3211 Clinical Trial.

Ming-Huang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.